Cullinan Therapeutics, Inc. CGEM · News

109

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for auto...

Price11.73

Market Cap720.9 M

Float48.2 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Search in Documents